CSPC Pharmaceutical Group Limited (FRA:CVG)

Germany flag Germany · Delayed Price · Currency is EUR
1.127
+0.002 (0.18%)
At close: Feb 20, 2026
Market Cap13.06B +106.9%
Revenue (ttm)3.14B -13.4%
Net Income486.22M -21.2%
EPS0.04 -18.9%
Shares Outn/a
PE Ratio26.87
Forward PE18.60
Dividend0.03 (2.37%)
Ex-Dividend DateOct 17, 2025
Volumen/a
Average Volume1,367
Open1.127
Previous Close1.125
Day's Range1.127 - 1.127
52-Week Range0.516 - 1.249
Betan/a
RSI63.52
Earnings DateMar 20, 2026

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 19,266
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol CVG
Full Company Profile

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.

Financial numbers in CNY Financial Statements